首页> 美国卫生研究院文献>Frontiers in Immunology >Regulatory Multitasking of Tolerogenic Dendritic Cells – Lessons Taken from Vitamin D3-Treated Tolerogenic Dendritic Cells
【2h】

Regulatory Multitasking of Tolerogenic Dendritic Cells – Lessons Taken from Vitamin D3-Treated Tolerogenic Dendritic Cells

机译:耐受性树突状细胞的调节性多任务处理-维生素D3处理的耐受性树突状细胞的经验教训

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Tolerogenic dendritic cells (DCs) work through silencing of differentiated antigen-specific T cells, activation and expansion of naturally occurring T regulatory cells (Tregs), transfer of regulatory properties to T cells, and the differentiation of naïve T cells into Tregs. Due to an operational definition based on T cell activation assays, the identity of tolerogenic DCs has been a matter of debate and it need not represent a specialized DC subset. Human tolerogenic DCs generated in vitro using inhibitory cytokines, growth factors, natural immunomodulators, or genetic manipulation have been effective and several of these tolerogenic DCs are currently being tested for clinical use. Ex vivo generated tolerogenic DCs reduce activation of naïve T cells using various means, promote a variety of regulatory T cells and most importantly, frequently show stable inhibitory phenotypes upon repetitive maturation with inflammatory factors. Yet, tolerogenic DCs differ with respect to the phenotype or the number of regulatory mechanisms they employ to modulate the immune system. In our experience, tolerogenic DCs generated using the biologically active form of vitamin D (VD3-DCs), alone, or combined with dexamethasone are proficient in their immunoregulatory functions. These tolerogenic DCs show a stable maturation-resistant semi-mature phenotype with low expression of activating co-stimulatory molecules, no production of the IL-12 family of cytokines and high expression of inhibitory molecules and IL-10. VD3-DCs induce increased apoptosis of effector T cells and induce antigen-specific regulatory T cells, which work through linked suppression ensuring infectious tolerance. Lessons learned on VD3-DCs help understanding the contribution of different pattern-recognition receptors (PRRs) and secondary signals to the tolerogenic function and how a cross-talk between DCs and T cells translates into immune regulation.
机译:致耐受性树突状细胞(DC)通过沉默分化的抗原特异性T细胞,激活和扩展天然T调节细胞(Tregs),将调节特性转移到T细胞以及将幼稚T细胞分化为Treg来发挥作用。由于基于T细胞活化试验的操作定义,致耐受DC的身份一直是一个争论的问题,它不必代表专门的DC子集。使用抑制性细胞因子,生长因子,天然免疫调节剂或基因操作在体外产生的人类致耐受性DC是有效的,目前正在测试其中一些致耐受性DC的临床应用。离体产生的致耐受性DC可通过多种方式减少幼稚T细胞的活化,促进多种调节性T细胞,最重要的是,在与炎症因子重复成熟后,常常表现出稳定的抑制表型。然而,致耐受性DC在其用来调节免疫系统的表型或调节机制的数量方面有所不同。根据我们的经验,使用维生素D(VD3-DCs)的生物活性形式单独或与地塞米松组合产生的致耐受性DC均具有出色的免疫调节功能。这些具有耐受力的DC表现出稳定的抗成熟半成熟表型,具有低水平的活化共刺激分子表达,不产生IL-12家族的细胞因子以及高表达的抑制性分子和IL-10。 VD3-DCs诱导效应T细胞凋亡增加,并诱导抗原特异性调节性T细胞,它们通过连锁抑制作用来确保感染耐受。在VD3-DC上获得的经验教训有助于理解不同的模式识别受体(PRR)和次级信号对致耐受功能的作用,以及DC和T细胞之间的串扰如何转化为免疫调节。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号